Yoshihiko Maeta

Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer

Masahide Ikeguchi, Manabu Yamamoto, Yosuke Arai et al. · Oncology Letters · 2011 · 109 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +10

The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma

Kenji Fukuda, Shunichi Tsujitani, Yoshihiko Maeta et al. · Gastric Cancer · 2002 · 45 citations · Full text

T-regulatory Cell, Immunology, Pathology +7

Advanced cancer with situs inversus totalis associated with KIF3 complex deficiency: Report of two cases

Tomohiro Haruki, Yoshihiko Maeta, Seiichi Nakamura et al. · Surgery Today · 2010 · 41 citations

Tumor Biology, Advanced Cancer, Tumoral Pathology +8

Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma

Yoshihiko Maeta, Shunichi Tsujitani, Sachiko Matsumoto et al. · Gastric Cancer · 2004 · 27 citations · Full text

Medicine, P53 Proteins, Pathology +9

Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients

Manabu Yamamoto, Hiroaki Saito, Chihiro Uejima et al. · Surgery Today · 2018 · 24 citations

Prognostic Biomarkers, Surgical Oncology, Postoperative C-reactive Protein +12